Angela A. Garibaldi Week 11
From OpenWetWareJump to navigationJump to search
- 1 OUTLINE of Transcriptional Signature following Inhibition of Early-Stage Cell Wall Biosynthesis in Staphylococcus aureus
- 2 Navigation
OUTLINE of Transcriptional Signature following Inhibition of Early-Stage Cell Wall Biosynthesis in Staphylococcus aureus
- Studying the Mode Of Action of how antibacterial agents, such as antibiotics, work is important in coming up with new antibacterials against Staph aureus in light of all of the resistance issues.
- Analyzing structure-activity relationships are key in developing new antibiotics to attack staph in a novel way to avoid resistance
- DNA microarrays is a good way to do transcriptional profiling to see the cellular response to a novel antibacterial across the entire genome.
- The MOA of a new antibacterial can be predicted by comparing the profile with that of a profile from an antibiotic with a previously well characterized MOA.
Review of Common Antibacterial Inhibitor Mechanism
- Targets Cell wall biosynthesis (CWB) to kill Staph aureus
- Researchers are trying to come up with an antibacterial inhibitor that targets the early stage of CWB via the Mur enzymes
- This stage I or Cytoplasmic stage of peptidoglycan synthesis has not been widely targeted in recent studies, providing a great potential avenue to find an antibacterial with a different system of effectiveness.
- Previous studies have characterized transcriptional responses of genes being downregulated or upregulated in response to antibiotics that target the later stages of CWB such as vanomycin and oxacillin
- So far only fosfomycin is the only Mur enzyme inhibitor that inhibits the earlier stage of CWB by affecting the function of MurA and MurZ.
- Create universal transcriptional profile of S. aureus after the earlier stage (Stage I) is inhibited in CWB
- Use fosfomycin as test inhibitor (control)
- utilized genetic and postranslational challenge to inhibit/deplete the cell of other enzymes that are active in the early stage I of CWB
- S. aureus RN4220 and derivatives used
- Strain TS2557 has a mutation in MurB making it temperature sensitive
- CYL368 has been modified so that MurE is controlled by the Pspac promoter, meaning that its expression depends on the presence of IPTG
- CLY368 requires tetracycline in the growth medium to maintain the integrity of the lacI repressor plasmid (pMJ8246).
- pMJ8246 also put into RN4220 so that both conditional and control strains were subject to identical conditions (ie with tetracycline)
- Conditional mutants resulted in 80% inhibition of growth in mutant vs wild-type
- Drug-treated cultures exposed to a concentration of antibiotic causing 25% reduction in growth relative to untreated cultures after 40 minutes.
- Cyl368 and RN4220(pMJ8246) were grown overnight in presence of 3ug tetracycline and .3mM IPTG.
- Cells harvested, washed to remove IPTG
- Resuspended in fresh broth lacking IPTG at OD600 of .05
- Grow at 37C, harvest at OD600 of .25
- TS2557 and RN4220 grown overnight at 30C, resuspended to OD600 at .075 in fresh broth
- TS2557 and RN4220 grown at 42C and harvested at OD600 of .25
- O/N RN4220 at 37C used to inoculate prewarmed TSB to OD600 of .02 and grown at 37C to OD600 of .1
- Culture split into 2 prewarmed flasks (one of these has fosfomycin), harvest cells after 40 min incubation
- RNA midi kit from cells treated with lysostaphin.
- Control RNA and sample RNA used to make cDNA by reverse transcription that will be differentially labeled in presence of Cy3 and Cy5 fluorescent dyes.
- Both control and sample RNA are cohybridized, scanned, analyzed.
- Cultures grown in triplicate
- Hybridized in duplicate for a total of 6 arrays per condition.
- Dye swap design in which label orientations are reversed
- Feature extraction via ImageGeneSoftware
- Fluorescent intensities processed via MAVI Pro software
- Normalization via GeneSpring v7.3.1 software
- Differentially expressed genes for each condition identified
- There were 3 biological replicates:
- S. aureus with MurA inhibition
- S. aureus with MurB inhibition
- S. aureus with MurE inhibition
- There were 2 technical replicates
- 18 hybridizations
- shows the pathway of stage I CWB, involving the biosynthesis of UDP-MurNAc-pentapeptide from UDP-GlcNAc, mediated by the Mur enzymes
- Inhibition in the pathway was achieved at
- MurB (thermosensitive protein)
- MurE (conditional gene expression)
- Genes subject to same level of deregulation under all three (inhibition/depletion of MurA or MurZ, MurB, and MurE) were considered members of the transcriptional signature for inhibition of CWB.
- Transcriptional signature showed upregulation of genes involved in providing precursors that are essential for CWB (gltAB, oppABCDF, dapABD, asd, thrBC, dhoM, ilvBCD, leuABCD), and genes involved in the response to environmental stress (ctsR, clpB, msrA2, katA)
- Little deregulation detected in genes encoding enzymes directly involved in CWB or cell wall turnover EXCEPT for upregulation of dal, sgtB and downregulation of atl.
- No consistent deregulation in expression of the Mur enzymes was observed
- This suggests that the expression of genes involved in stage I peptidoglycan synthesis in S. aureus is essential and that CWB is unrestricted up to, and including, synthesis of the UDPMur-NAc pentapeptide
- Accomplished the universal transcriptional signature for inbibition of stage I CWB,
- This was derived from the transcriptional signature for inbition of CWB by including only genes that were similarly deregulated following conditinoal depletion of MurF in a previous study
- Then subtracting all genes known to be deregulated following exposure to inhibitors of stage II/III CWB (bacitracin, vancomycin, oxacillin, and cefoxitin.
- Results suggest that transcriptional profiling can be employed to identify inhibitors of CWB and to specify whether they act on early or later stages in the biosynthetic pathway.
Microarray data accession number
Fully annotated microarray data in BμG@Sbase (accession number EBUGS-71) and ArrayExpress with same accession number
- cytoplasmic stage -
- peptidoglycan - A polymer that serves a structural role in the bacterial cell wall, giving structural strength, as well as counteracting the osmotic pressure of the cytoplasm. It is also involved in binary fission during bacterial cell reproduction. Biology Dictionary
- repressor plasmid -
- lysostaphin - an antimicrobial enzyme that is obtained from a strain of staphylococcus and is effective against other staphylococci Merriam Webster
- cohybridize -
- feature extraction - In pattern recognition and in image processing, feature extraction is a special form of dimensionality reduction.When the input data to an algorithm is too large to be processed and it is suspected to be notoriously redundant (much data, but not much information) then the input data will be transformed into a reduced representation set of features (also named features vector). Transforming the input data into the set of features is called feature extraction. If the features extracted are carefully chosen it is expected that the features set will extract the relevant information from the input data in order to perform the desired task using this reduced representation instead of the full size input. Wiki
- chaperone - a family of proteins that aid in the folding of target proteins. Medical Dictionary
- feature - spots of DNA oligonuleotides each containing picomoles of the probe Wiki
- Spac promoter - a promoter hybrid that contains the lac operator region and is used to modulate expression through IPTG induction which inhibits transcription of downstream genes.
- lac respressor (lacI) -is a DNA-binding protein which inhibits the expression of genes coding for proteins involved in the metabolism of lactose in bacteria. It is active in the absence of lactose, ensuring that the bacterium only invests energy in the production of machinery necessary for the uptake and metabolism of lactose when lactose is present. When lactose becomes available, it is converted into allolactose, which inhibits the lac repressor's DNA binding ability. Wiki
- Angela A. Garibaldi Week 2
- Angela A. Garibaldi Week 3
- Angela A. Garibaldi Week 4
- Angela A. Garibaldi Week 5
- Angela A. Garibaldi Week 6
- Angela A. Garibaldi Week 7
- Angela A. Garibaldi Week 8
- Angela A. Garibaldi Week 9
- Angela A. Garibaldi Week 10
- Angela A. Garibaldi Week 11
- Angela A. Garibaldi Week 12
- Angela A. Garibaldi Week 13
- Angela A. Garibaldi Week 14
- Angela A. Garibaldi GS Papers 1